DK1276469T3 - Smagsmaskerende overtrækssammensætning - Google Patents

Smagsmaskerende overtrækssammensætning

Info

Publication number: DK1276469T3
Authority: DK; Denmark
Prior art keywords: coating composition; taste; masking coating; active ingredient; masks
Prior art date: 2000-04-20

Application number

DK01928678T

Other languages

English (en)

Inventor

Michael Corbo

Jatin Desai

Mahesh Patell

Ronald Warrick

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-20

Filing date

2001-04-19

Publication date

2007-10-15

2001-04-19 Application filed by Novartis Ag filed Critical Novartis Ag

2007-10-15 Application granted granted Critical

2007-10-15 Publication of DK1276469T3 publication Critical patent/DK1276469T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
General Preparation And Processing Of Foods (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Seasonings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

DK01928678T 2000-04-20 2001-04-19 Smagsmaskerende overtrækssammensætning DK1276469T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/553,513 US6551617B1 (en)	2000-04-20	2000-04-20	Taste masking coating composition
PCT/US2001/012805 WO2001080829A2 (en)	2000-04-20	2001-04-19	Taste masking coating composition

Publications (1)

Publication Number	Publication Date
DK1276469T3 true DK1276469T3 (da)	2007-10-15

Family

ID=24209676

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01928678T DK1276469T3 (da)	2000-04-20	2001-04-19	Smagsmaskerende overtrækssammensætning

Country Status (16)

Country	Link
US (1)	US6551617B1 (da)
EP (1)	EP1276469B1 (da)
JP (1)	JP2003531163A (da)
KR (1)	KR100780156B1 (da)
CN (1)	CN1423555A (da)
AT (1)	ATE364378T1 (da)
AU (2)	AU2001255509B2 (da)
BR (1)	BR0109925A (da)
CA (1)	CA2407072C (da)
DE (1)	DE60128901T2 (da)
DK (1)	DK1276469T3 (da)
ES (1)	ES2286119T3 (da)
MX (1)	MXPA02010332A (da)
PT (1)	PT1276469E (da)
WO (1)	WO2001080829A2 (da)
ZA (1)	ZA200207648B (da)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8071128B2 (en)	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
GB9703673D0 (en) *	1997-02-21	1997-04-09	Bradford Particle Design Ltd	Method and apparatus for the formation of particles
DE19961897A1 (de) *	1999-12-20	2001-06-28	Basf Ag	Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
KR100523242B1 (ko) *	2000-05-18	2005-10-24	한미약품 주식회사	이부프로펜을 함유하는 정제 조성물
GB0027357D0 (en)	2000-11-09	2000-12-27	Bradford Particle Design Plc	Particle formation methods and their products
US6926938B2 (en) *	2001-01-10	2005-08-09	Suheung Capsule Co., Ltd.	Hardshell gelatin capsule reducing the static electricity and enhancing the lubrication of film
US7842308B2 (en) *	2001-01-30	2010-11-30	Smithkline Beecham Limited	Pharmaceutical formulation
US7883721B2 (en) *	2001-01-30	2011-02-08	Smithkline Beecham Limited	Pharmaceutical formulation
US20050175687A1 (en) *	2001-01-30	2005-08-11	Mcallister Stephen M.	Pharmaceutical formulations
GB0102342D0 (en) *	2001-01-30	2001-03-14	Smithkline Beecham Plc	Pharmaceutical formulation
WO2002067905A1 (en) *	2001-02-27	2002-09-06	Kos Pharmaceuticals, Inc.	A sustained release pharmaceutical formulation
GB0111077D0 (en) *	2001-05-04	2001-06-27	Biochemie Gmbh	Organic compounds
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
EP1446102A1 (en)	2001-11-21	2004-08-18	Alexza Molecular Delivery Corporation	Delivery of caffeine through an inhalation route
US20030175342A1 (en) *	2002-03-14	2003-09-18	Karl Kolter	Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
DE10211289A1 (de) *	2002-03-14	2003-09-25	Basf Ag	Kombination von Polyvinylacetat von wasserunlöslichen, säureunlöslichen oder alkaliunlöslichen Polymeren zur Hestellung von Filmüberzügen mit sehr kontrollierter Freisetzung und hoher Stabilität
GB0216562D0 (en) *	2002-04-25	2002-08-28	Bradford Particle Design Ltd	Particulate materials
US9339459B2 (en)	2003-04-24	2016-05-17	Nektar Therapeutics	Particulate materials
US20040033959A1 (en) *	2002-07-19	2004-02-19	Boehringer Ingelheim Pharmaceuticals, Inc.	Pharmaceutical compositions for hepatitis C viral protease inhibitors
US8367111B2 (en) *	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
US20060233873A1 (en) *	2003-01-24	2006-10-19	Julien Meissonnier	Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
WO2004087111A1 (en) *	2003-04-04	2004-10-14	Ranbaxy Laboratories Limited	Oral taste masked pharmaceutical compositions
WO2004098561A2 (en)	2003-05-08	2004-11-18	Nektar Therapeutics Uk Ltd	Particulate materials
EP1625336B9 (en)	2003-05-21	2012-03-21	Alexza Pharmaceuticals, Inc.	Use of a layer of solid fuel, method for producing such a layer and associated heating unit
TW200526274A (en) *	2003-07-21	2005-08-16	Smithkline Beecham Plc	Pharmaceutical formulations
WO2005013944A1 (en) *	2003-08-11	2005-02-17	Merck Frosst Canada Ltd.	Flavored taste-masked pharmaceutical formulation made using a one-step coating process
US7201920B2 (en)	2003-11-26	2007-04-10	Acura Pharmaceuticals, Inc.	Methods and compositions for deterring abuse of opioid containing dosage forms
AR048033A1 (es) *	2004-03-12	2006-03-22	Smithkline Beecham Plc	Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
US20060039966A1 (en) *	2004-08-12	2006-02-23	Miller Bruce A Jr	Dosage delivery apparatus for improving user acceptance of oral supplements and medicaments and methods for manufacturing same
US8747895B2 (en) *	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
US20060127479A1 (en) *	2004-10-08	2006-06-15	Natrajan Kumaraperumal	Solvent free taste masked pharmaceutical compositions
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
NZ589750A (en)	2004-10-21	2012-07-27	Aptalis Pharmatech Inc	Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) *	2004-11-12	2006-05-18	Eurand Pharmaceuticals Limited	Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en)	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
CN1883456B (zh) *	2005-06-20	2010-12-15	常州市第四制药厂有限公司	掩味药物颗粒及其制备方法和用途
KR100788449B1 (ko) *	2005-11-08	2008-01-02	주식회사 일신케미칼	덱시부프로펜 현탁원료 및 현탁액제의 제조방법
US20070141147A1 (en) *	2005-12-21	2007-06-21	Auriga Laboratories, Inc.	Sequential release pharmaceutical formulations
WO2007087188A2 (en) *	2006-01-20	2007-08-02	Merck & Co., Inc.	Taste-masked tablets and granules
EP2018160B1 (en)	2006-03-16	2011-12-14	Tris Pharma, Inc.	Modified release formulations containing drug-ion exchange resin complexes
US20100226979A1 (en) *	2006-03-21	2010-09-09	Jubilant Organosys Limited	Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate
US20070286903A1 (en) *	2006-06-13	2007-12-13	Becicka Brian T	Composition and method for taste masking
US20070289596A1 (en) *	2006-06-14	2007-12-20	Campbell Shannon E	Endotracheal cuff and technique for using the same
US20080064694A1 (en) *	2006-09-11	2008-03-13	Auriga Laboratories, Inc.	Multi-Phase Release Methscopolamine Compositions
US20080069874A1 (en) *	2006-09-15	2008-03-20	Auriga Laboratories, Inc.	Kits for Prevention and Treatment of Rhinitis
US20080085312A1 (en) *	2006-10-04	2008-04-10	Auriga Laboratories, Inc.	Multi-Phase Release Potassium Guaiacolsulfonate Compositions
WO2008112661A2 (en)	2007-03-09	2008-09-18	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
EP2320876A2 (en) *	2008-06-13	2011-05-18	Pfizer Inc.	Hydroxypropyl cellulose capsule shell
US20100124568A1 (en) *	2008-11-20	2010-05-20	Med-Eez, Inc	Pharmaceutical articles coated with lubricious coatings
US8901113B2 (en)	2009-09-30	2014-12-02	Acura Pharmaceuticals, Inc.	Methods and compositions for deterring abuse
CN102958515A (zh)	2009-12-02	2013-03-06	阿普塔利斯制药有限公司	非索非那定微胶囊及含有非索非那定微胶囊的组合物
AR079862A1 (es) *	2010-01-08	2012-02-22	Eurand Inc	Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
WO2012041788A1 (de) *	2010-09-27	2012-04-05	Basf Se	Protektive überzüge für saure wirkstoffe
MX350838B (es)	2011-02-11	2017-09-18	Grain Proc Corporation *	Composicion de sal.
EP2919903B1 (en)	2012-11-14	2020-07-22	W.R. Grace & CO. - CONN.	Compositions containing a biologically active material and a non-ordered inorganic oxide
CN104968333B (zh)	2012-11-30	2018-07-10	阿库拉制药公司	活性药物成分的自调节释放
JP2014166994A (ja) *	2013-02-04	2014-09-11	Rohto Pharmaceut Co Ltd	新規な漢方エキス製剤
US9233074B2 (en) *	2013-03-01	2016-01-12	Bpsi Holdings, Llc	Delayed release film coatings containing calcium silicate and substrates coated therewith
EP3122336A4 (en)	2014-03-26	2017-10-25	Sun Pharma Advanced Research Company Ltd	Abuse deterrent immediate release biphasic matrix solid dosage form
TR201618030T2 (tr)	2014-08-14	2018-09-21	Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi	Tadı düzeltilmiş parasetamol formülasyonları.
CN106389339B (zh) *	2015-08-12	2020-08-04	北京科信必成医药科技发展有限公司	一种阿司匹林无水吞服掩味颗粒及其制备方法
WO2017040607A1 (en)	2015-08-31	2017-03-09	Acura Pharmaceuticals, Inc.	Methods and compositions for self-regulated release of active pharmaceutical ingredient
US11590228B1 (en)	2015-09-08	2023-02-28	Tris Pharma, Inc	Extended release amphetamine compositions
GR1008992B (el)	2015-12-17	2017-03-23	Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων	Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης
WO2018055641A1 (en) *	2016-09-20	2018-03-29	Rubicon Research Private Limited	Oral modified release formulations
US11590081B1 (en)	2017-09-24	2023-02-28	Tris Pharma, Inc	Extended release amphetamine tablets
US12458592B1 (en)	2017-09-24	2025-11-04	Tris Pharma, Inc.	Extended release amphetamine tablets
EP3746138B1 (en)	2018-02-02	2025-12-10	Alexza Pharmaceuticals, Inc.	Electrical condensation aerosol device

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3453360A (en)	1966-04-27	1969-07-01	Abbott Lab	Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
AT270071B (de)	1966-08-12	1969-04-10	Roehm & Haas Gmbh	Dragierlack für Arzneiformen
ZA718014B (en) *	1970-12-23	1972-08-30	Beecham Group Ltd	Pharmaceutical formulations
DE2340060A1 (de)	1973-08-08	1975-02-20	Scherer Gmbh R P	Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
DE3049179A1 (de)	1975-03-20	1982-07-29	Röhm GmbH, 6100 Darmstadt	Bindemittel fuer arzneimittelueberzuege.
JPS5840529B2 (ja)	1975-09-29	1983-09-06	明治製菓株式会社	ケイコウヨウセイザイノセイホウ
CA1125698A (en)	1978-03-09	1982-06-15	Masaru Yoshida	Process for preparing a polymer composition
US4321253A (en)	1980-08-22	1982-03-23	Beatty Morgan L	Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv)	1981-06-18	1982-12-19	Astra Laekemedel Ab	Farmaceutisk mixtur
US4587118A (en)	1981-07-15	1986-05-06	Key Pharmaceuticals, Inc.	Dry sustained release theophylline oral formulation
US4749575A (en)	1983-10-03	1988-06-07	Bio-Dar Ltd.	Microencapsulated medicament in sweet matrix
IT1188212B (it)	1985-12-20	1988-01-07	Paolo Colombo	Sistema per il rilascio a velocita' controllata di sostanze attive
US4710384A (en)	1986-07-28	1987-12-01	Avner Rotman	Sustained release tablets made from microcapsules
US4760093A (en)	1986-10-21	1988-07-26	American Home Products Corporation (Del.)	Spray dried acetaminophen
US4800087A (en)	1986-11-24	1989-01-24	Mehta Atul M	Taste-masked pharmaceutical compositions
KR960011236B1 (ko)	1987-05-08	1996-08-21	스미스 클라인 앤드 프렌취 라보라토리스 리미티드	제약학적 조성물 및 고체 제형
US4851226A (en)	1987-11-16	1989-07-25	Mcneil Consumer Products Company	Chewable medicament tablet containing means for taste masking
JPH0273011A (ja)	1988-07-28	1990-03-13	Warner Lambert Co	医薬投与剤型製造用のセルロースおよびアクリル系重合体の水性重合体分散体およびその投与剤型
DE3900811A1 (de)	1989-01-13	1990-07-19	Kali Chemie Pharma Gmbh	Neue arzneiform
DK0524180T3 (da)	1990-04-11	1995-09-04	Upjohn Co	Smagsmaskering af ibuprofen ved fluid bedovertrækning
IT1246383B (it)	1990-04-17	1994-11-18	Eurand Int	Metodo per il mascheramento del sapore di farmaci
CA2068402C (en)	1991-06-14	1998-09-22	Michael R. Hoy	Taste mask coatings for preparation of chewable pharmaceutical tablets
JP3265680B2 (ja)	1992-03-12	2002-03-11	大正製薬株式会社	経口製剤用組成物
WO1994010983A1 (fr)	1992-11-06	1994-05-26	Hisamitsu Pharmaceutical Co., Inc.	Preparation pharmaceutique perorale liberable dans le tube digestif inferieur
US5260069A (en)	1992-11-27	1993-11-09	Anda Sr Pharmaceuticals Inc.	Pulsatile particles drug delivery system
CA2110313C (en) *	1992-12-01	2004-10-26	Edward John Roche	Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US5639475A (en)	1995-02-03	1997-06-17	Eurand America, Incorporated	Effervescent microcapsules
ES2203963T3 (es) *	1997-05-30	2004-04-16	Osmotica Corp.	Dispositivo osmotico multicapa.
DE19961897A1 (de)	1999-12-20	2001-06-28	Basf Ag	Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
SE0001151D0 (sv) *	2000-03-31	2000-03-31	Amarin Dev Ab	Method for producing a controlled-release composition

2000
- 2000-04-20 US US09/553,513 patent/US6551617B1/en not_active Expired - Lifetime
2001
- 2001-04-19 ES ES01928678T patent/ES2286119T3/es not_active Expired - Lifetime
- 2001-04-19 KR KR1020027014070A patent/KR100780156B1/ko not_active Expired - Fee Related
- 2001-04-19 DE DE60128901T patent/DE60128901T2/de not_active Expired - Lifetime
- 2001-04-19 BR BR0109925-6A patent/BR0109925A/pt not_active Application Discontinuation
- 2001-04-19 CA CA2407072A patent/CA2407072C/en not_active Expired - Fee Related
- 2001-04-19 DK DK01928678T patent/DK1276469T3/da active
- 2001-04-19 MX MXPA02010332A patent/MXPA02010332A/es active IP Right Grant
- 2001-04-19 AU AU2001255509A patent/AU2001255509B2/en not_active Ceased
- 2001-04-19 AT AT01928678T patent/ATE364378T1/de active
- 2001-04-19 EP EP01928678A patent/EP1276469B1/en not_active Expired - Lifetime
- 2001-04-19 JP JP2001577929A patent/JP2003531163A/ja active Pending
- 2001-04-19 WO PCT/US2001/012805 patent/WO2001080829A2/en not_active Ceased
- 2001-04-19 CN CN01808166A patent/CN1423555A/zh active Pending
- 2001-04-19 AU AU5550901A patent/AU5550901A/xx active Pending
- 2001-04-19 PT PT01928678T patent/PT1276469E/pt unknown
2002
- 2002-09-23 ZA ZA200207648A patent/ZA200207648B/en unknown

Also Published As

Publication number	Publication date
AU2001255509B2 (en)	2005-11-24
KR100780156B1 (ko)	2007-11-27
JP2003531163A (ja)	2003-10-21
CA2407072A1 (en)	2001-11-01
KR20030023860A (ko)	2003-03-20
BR0109925A (pt)	2003-06-10
WO2001080829A2 (en)	2001-11-01
EP1276469B1 (en)	2007-06-13
CN1423555A (zh)	2003-06-11
DE60128901D1 (de)	2007-07-26
PT1276469E (pt)	2007-09-11
CA2407072C (en)	2010-06-15
MXPA02010332A (es)	2003-05-23
DE60128901T2 (de)	2008-02-28
ATE364378T1 (de)	2007-07-15
US6551617B1 (en)	2003-04-22
WO2001080829A3 (en)	2002-03-21
AU5550901A (en)	2001-11-07
ES2286119T3 (es)	2007-12-01
ZA200207648B (en)	2003-12-23
EP1276469A2 (en)	2003-01-22

Publication	Publication Date	Title
DK1276469T3 (da)	2007-10-15	Smagsmaskerende overtrækssammensætning
DK1276470T3 (da)	2007-06-18	Smagskaskerende overtrækssammensætning
SE9704869D0 (sv)	1997-12-22	New pharmaceutical formulaton II
DK1296670T3 (da)	2006-05-08	Terapeutiske fedtsyrekombinationer
WO2004056337A3 (en)	2004-08-19	Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
ATE486840T1 (de)	2010-11-15	Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
ATE391496T1 (de)	2008-04-15	Geschmacksmaskierte pharmazeutische formulierungen
NO20032593L (no)	2003-08-05	Farmasoytisk fremstilling omfattende en aktiv bestanddel dispergert pa en matrise
DK1392276T3 (da)	2007-05-07	Forstærkning af terapeutiske effekter af flerumættede fedtsyrer
ES2275716T3 (es)	2007-06-16	Composicion farmaceutica de liberacion transdermica.
NO20016346D0 (no)	2001-12-21	Ny formulering
ATE425744T1 (de)	2009-04-15	Pharmazeutische formulierungen mit verbesserter bioverfugbarkeit
EP1595539A4 (en)	2007-04-11	DRUGS TO REDUCE THE SIDE EFFECTS OF RIBAVIRIN INTERFERON COMBINATION THERAPY
BRPI0412697A (pt)	2006-10-03	composições farmacêuticas que apresentam um revestimento expansìvel
BR0007294A (pt)	2002-08-27	Formulações farmacêuticas aperfeiçoadas
NO20073457L (no)	2007-09-05	Stabile sammensetninger av fenofibrat med fettsyreestere
DK1414467T3 (da)	2006-08-28	Topisk behandling af mastalgi
SE0001916D0 (sv)	2000-05-23	Novel formulation
DE60121142D1 (de)	2006-08-10	Zusammensetzung die paracetamol und niflumic säure enthält
BR0113055A (pt)	2003-07-08	Preparação sólida altamente absorvìvel
JP2005154283A5 (da)	2005-12-02
TNSN00242A1 (en)	2002-05-30	VALDECOXIB COMPOSITIONS